Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor.

Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor. Abstract Text:

G Mathé,O Halle-Pannenko,C Bourut,

The therapeutic value of interspersing cyclophosphamide (CPM) chemotherapy and BCG immunotherapy was investigated in two tumor models: L1210 leukemia and Lewis solid tumor (LLT). In the case of L1210 leukemia, the antileukemic effect of CPM was enhanced by subsequent BCG administration where a single cycle of combined treatment was applied; treatment by repeated doses of CPM interspersed with BCG was no more effective than CPM chemotherapy alone. In the case of LLT tumor, the effect of one cycle of combined CPM-BCG treatment was not different from CPM administered alone but treatment by repeated doses of CPM interspersed with BCG immunotherapy was less effective than CPM chemotherapy alone. These results indicate that, while the effect of BCG immunotherapy may be favorable or nil when BCG is applied after cell-reducing chemotherapy, it may be nil or unfavorable when applied repeatedly in interspersed chemoimmunotherapy treatments.

Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor. Publishing Authors By Initials

G Mathé,O Halle-Pannenko,C Bourut,

For similar neoplasms: neoplasms, experimental research abstracts see: neoplasms: neoplasms, experimental research

PUBMED ID PMID:

MEDLINE DATE:

Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Recent results in cancer research. Fortschritte de

VOLUME:

Page Numbers: 62-6

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1977

Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor. Keywords Mesh Terms:

KEYWORDS: Neoplasms, Experimental

MESH TERMS: therapy

Chemical & Substance for Abstract: Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor. Information

Substance Name: Cyclophosphamide

Registry Number: 50-18-0

Grant and Affiliation Information for Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor Related Publications

• Effectiveness of murine leukemia chemotherapy according to the immune state: reconsideration of correlations between chemotherapy, tumour cell killing, and survival time.
• Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor.